Sublingual Allergy Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

Unprecedented Expansion Predicted, Driven by Rising Allergy Prevalence and Technological Advancements

The global sublingual allergy immunotherapy (SLIT) market is anticipated to witness remarkable growth in the coming years, reaching a valuation of US$ 1.0 billion by the end of 2031. This projection, derived from Fairfield Market Research's latest analysis, highlights a compound annual growth rate (CAGR) of 12.0% from 2024. This surge in demand is fueled by several factors, including the escalating burden of allergic diseases, heightened awareness of food allergies, and advancements in medical technology.

Epidemiological Shifts Propel Market Expansion

Recent years have seen a notable surge in the prevalence of allergic disorders worldwide. According to a 2019 study published in the National Library of Medicine, allergic disorders collectively impact 20% of the global population. This alarming trend, coupled with a rising incidence of food allergies, allergic rhinitis, and other atopic illnesses, is driving the demand for effective allergy management solutions.

Innovative Solutions Drive Market Momentum

Technological innovations, particularly in the realm of molecular diagnostics and genetic testing, are revolutionizing allergy diagnosis and treatment. These advancements facilitate precise diagnosis and personalized therapy planning, thereby enhancing patient outcomes. Moreover, the increasing acceptance of advanced medical technologies, particularly in emerging economies, is propelling market growth.

Rise in Research Investments Fuels Product Development

Key players in the pharmaceutical industry are intensifying their focus on research and development to commercialize advanced allergy immunotherapy products. With more than 40 products currently in clinical trials, the market is poised to witness a wave of innovative treatments in the next 2 to 3 years. Notably, efforts are underway to develop immunotherapy treatments specifically targeting food allergies, addressing a critical unmet need in the market.

Challenges Impeding Market Growth

Despite the promising outlook, certain challenges hinder the widespread adoption of sublingual allergy immunotherapy. High treatment costs, prolonged therapy duration, and the risk of adverse effects pose significant barriers to patient compliance. Additionally, unfavorable side effects associated with some medications, including redness, swelling, and in rare cases, anaphylaxis, underscore the importance of continuous research to enhance treatment safety and efficacy.

Country-Specific Dynamics

Germany Emerges as a Key Market: With a robust regulatory framework governing allergy medications, Germany represents a lucrative market for manufacturers of sublingual allergy immunotherapy drugs. High prevalence of allergies and accessibility to a variety of treatment options contribute to the country's dominance in the European market.
United States Leads North American Market: Growing public awareness about allergies and the availability of effective long-term solutions drive the demand for SLIT in the United States. Pharmaceutical companies are actively engaged in research, development, and promotional activities to cater to the expanding patient population.
China Witnessing Surge in Adoption: Government initiatives aimed at promoting allergy management have spurred the adoption of sublingual immunotherapy in China. Increased awareness and improved access to healthcare services are contributing to the growing demand for SLIT treatments in the region.

Competitive Analysis

Leading manufacturers in the sublingual allergy immunotherapy market are poised to capitalize on the burgeoning demand for innovative allergy treatments. These companies are actively expanding their presence in new markets while maintaining strategic partnerships with distributors to ensure widespread accessibility of their products.

Key Companies Covered in the sublingual allergy immunotherapy market, including:

ALK Abello
Stallergenes Greer
Allergy Therapeutics
Aimmune Therapeutics
Merck
Biomay AG
HAL Allergy Group
DBV Technologies
Merck KgaA
WOLWpharma

Key Segments of SLIT Industry Research

Drug:

Odactra
Grastek
Ragwitek
Oralair
Actair
Others

Indication:

Allergic Rhinitis
Allergic Asthma
Food Allergy
Atopic Dermatitis
Others

Allergen:

Pollen
- Grass Pollen
- Weed Pollen
- Tree Pollen
House Dust Mites
Mold
Animal Dander
Bee Venom
Cockroaches/Insects
Others

Distribution Channel:

Institutional Sales
- Government Hospitals
- Semi-Government Hospitals
- Private Hospitals
Retail Sales
- Retail Pharmacies
- Drug Stores
- Online Pharmacies

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Sublingual Allergy Immunotherapy Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Sublingual Allergy Immunotherapy Market Outlook, 2018 - 2031

3.1. Global Sublingual Allergy Immunotherapy Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Odactra
  - 3.1.1.2. Grastek
  - 3.1.1.3. Ragwitek
  - 3.1.1.4. Oralair
  - 3.1.1.5. Actair
  - 3.1.1.6. Others
3.2. Global Sublingual Allergy Immunotherapy Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Allergic Rhinitis
  - 3.2.1.2. Allergic Asthma
  - 3.2.1.3. Food Allergy
  - 3.2.1.4. Atopic Dermatitis
  - 3.2.1.5. Others
3.3. Global Sublingual Allergy Immunotherapy Market Outlook, by Allergen Type, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Pollen
    - 3.3.1.1.1. Grass Pollen
    - 3.3.1.1.2. Weed Pollen
    - 3.3.1.1.3. Tree Pollen
  - 3.3.1.2. House Dust Mites
  - 3.3.1.3. Mold
  - 3.3.1.4. Animal Dander
  - 3.3.1.5. Bee Venom
  - 3.3.1.6. Cockroaches/Insects
  - 3.3.1.7. Others
3.4. Global Sublingual Allergy Immunotherapy Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Institutional Sales
    - 3.4.1.1.1. Government Hospitals
    - 3.4.1.1.2. Semi-Government Hospitals
    - 3.4.1.1.3. Private Hospitals
  - 3.4.1.2. Retail Sales
    - 3.4.1.2.1. Retail Pharmacies
    - 3.4.1.2.2. Drug Stores
    - 3.4.1.2.3. Online Pharmacies
3.5. Global Sublingual Allergy Immunotherapy Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Sublingual Allergy Immunotherapy Market Outlook, 2018 - 2031

4.1. North America Sublingual Allergy Immunotherapy Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Odactra
  - 4.1.1.2. Grastek
  - 4.1.1.3. Ragwitek
  - 4.1.1.4. Oralair
  - 4.1.1.5. Actair
  - 4.1.1.6. Others
4.2. North America Sublingual Allergy Immunotherapy Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Allergic Rhinitis
  - 4.2.1.2. Allergic Asthma
  - 4.2.1.3. Food Allergy
  - 4.2.1.4. Atopic Dermatitis
  - 4.2.1.5. Others
4.3. North America Sublingual Allergy Immunotherapy Market Outlook, by Allergen Type, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Pollen
    - 4.3.1.1.1. Grass Pollen
    - 4.3.1.1.2. Weed Pollen
    - 4.3.1.1.3. Tree Pollen
  - 4.3.1.2. House Dust Mites
  - 4.3.1.3. Mold
  - 4.3.1.4. Animal Dander
  - 4.3.1.5. Bee Venom
  - 4.3.1.6. Cockroaches/Insects
  - 4.3.1.7. Others
4.4. North America Sublingual Allergy Immunotherapy Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Institutional Sales
    - 4.4.1.1.1. Government Hospitals
    - 4.4.1.1.2. Semi-Government Hospitals
    - 4.4.1.1.3. Private Hospitals
  - 4.4.1.2. Retail Sales
    - 4.4.1.2.1. Retail Pharmacies
    - 4.4.1.2.2. Drug Stores
    - 4.4.1.2.3. Online Pharmacies
- 4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Sublingual Allergy Immunotherapy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 4.5.1.2. U.S. Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 4.5.1.3. U.S. Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.4. U.S. Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 4.5.1.5. Canada Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 4.5.1.6. Canada Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 4.5.1.7. Canada Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.8. Canada Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Sublingual Allergy Immunotherapy Market Outlook, 2018 - 2031

5.1. Europe Sublingual Allergy Immunotherapy Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Odactra
  - 5.1.1.2. Grastek
  - 5.1.1.3. Ragwitek
  - 5.1.1.4. Oralair
  - 5.1.1.5. Actair
  - 5.1.1.6. Others
5.2. Europe Sublingual Allergy Immunotherapy Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Allergic Rhinitis
  - 5.2.1.2. Allergic Asthma
  - 5.2.1.3. Food Allergy
  - 5.2.1.4. Atopic Dermatitis
  - 5.2.1.5. Others
5.3. Europe Sublingual Allergy Immunotherapy Market Outlook, by Allergen Type, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Pollen
    - 5.3.1.1.1. Grass Pollen
    - 5.3.1.1.2. Weed Pollen
    - 5.3.1.1.3. Tree Pollen
  - 5.3.1.2. House Dust Mites
  - 5.3.1.3. Mold
  - 5.3.1.4. Animal Dander
  - 5.3.1.5. Bee Venom
  - 5.3.1.6. Cockroaches/Insects
  - 5.3.1.7. Others
5.4. Europe Sublingual Allergy Immunotherapy Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Institutional Sales
    - 5.4.1.1.1. Government Hospitals
    - 5.4.1.1.2. Semi-Government Hospitals
    - 5.4.1.1.3. Private Hospitals
  - 5.4.1.2. Retail Sales
    - 5.4.1.2.1. Retail Pharmacies
    - 5.4.1.2.2. Drug Stores
    - 5.4.1.2.3. Online Pharmacies
- 5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Sublingual Allergy Immunotherapy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 5.5.1.2. Germany Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.3. Germany Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.4. Germany Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.5.1.5. U.K. Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 5.5.1.6. U.K. Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.7. U.K. Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.8. U.K. Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.5.1.9. France Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 5.5.1.10. France Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.11. France Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.12. France Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.5.1.13. Italy Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 5.5.1.14. Italy Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.15. Italy Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.16. Italy Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.5.1.17. Turkey Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 5.5.1.18. Turkey Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.19. Turkey Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.20. Turkey Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.5.1.21. Russia Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 5.5.1.22. Russia Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.23. Russia Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.24. Russia Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.5.1.25. Rest of Europe Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 5.5.1.26. Rest of Europe Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 5.5.1.27. Rest of Europe Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.28. Rest of Europe Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Sublingual Allergy Immunotherapy Market Outlook, 2018 - 2031

6.1. Asia Pacific Sublingual Allergy Immunotherapy Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Odactra
  - 6.1.1.2. Grastek
  - 6.1.1.3. Ragwitek
  - 6.1.1.4. Oralair
  - 6.1.1.5. Actair
  - 6.1.1.6. Others
6.2. Asia Pacific Sublingual Allergy Immunotherapy Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Allergic Rhinitis
  - 6.2.1.2. Allergic Asthma
  - 6.2.1.3. Food Allergy
  - 6.2.1.4. Atopic Dermatitis
  - 6.2.1.5. Others
6.3. Asia Pacific Sublingual Allergy Immunotherapy Market Outlook, by Allergen Type, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Pollen
    - 6.3.1.1.1. Grass Pollen
    - 6.3.1.1.2. Weed Pollen
    - 6.3.1.1.3. Tree Pollen
  - 6.3.1.2. House Dust Mites
  - 6.3.1.3. Mold
  - 6.3.1.4. Animal Dander
  - 6.3.1.5. Bee Venom
  - 6.3.1.6. Cockroaches/Insects
  - 6.3.1.7. Others
6.4. Asia Pacific Sublingual Allergy Immunotherapy Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Institutional Sales
    - 6.4.1.1.1. Government Hospitals
    - 6.4.1.1.2. Semi-Government Hospitals
    - 6.4.1.1.3. Private Hospitals
  - 6.4.1.2. Retail Sales
    - 6.4.1.2.1. Retail Pharmacies
    - 6.4.1.2.2. Drug Stores
    - 6.4.1.2.3. Online Pharmacies
- 6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Sublingual Allergy Immunotherapy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 6.5.1.2. China Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.3. China Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.4. China Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.5.1.5. Japan Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 6.5.1.6. Japan Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.7. Japan Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.8. Japan Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.5.1.9. South Korea Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 6.5.1.10. South Korea Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.11. South Korea Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.12. South Korea Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.5.1.13. India Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 6.5.1.14. India Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.15. India Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.16. India Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.5.1.17. Southeast Asia Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 6.5.1.18. Southeast Asia Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.19. Southeast Asia Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.20. Southeast Asia Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Sublingual Allergy Immunotherapy Market Outlook, 2018 - 2031

7.1. Latin America Sublingual Allergy Immunotherapy Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Odactra
  - 7.1.1.2. Grastek
  - 7.1.1.3. Ragwitek
  - 7.1.1.4. Oralair
  - 7.1.1.5. Actair
  - 7.1.1.6. Others
7.2. Latin America Sublingual Allergy Immunotherapy Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
7.3. Latin America Sublingual Allergy Immunotherapy Market Outlook, by Allergen Type, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Pollen
    - 7.3.1.1.1. Grass Pollen
    - 7.3.1.1.2. Weed Pollen
    - 7.3.1.1.3. Tree Pollen
  - 7.3.1.2. House Dust Mites
  - 7.3.1.3. Mold
  - 7.3.1.4. Animal Dander
  - 7.3.1.5. Bee Venom
  - 7.3.1.6. Cockroaches/Insects
  - 7.3.1.7. Others
7.4. Latin America Sublingual Allergy Immunotherapy Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Institutional Sales
    - 7.4.1.1.1. Government Hospitals
    - 7.4.1.1.2. Semi-Government Hospitals
    - 7.4.1.1.3. Private Hospitals
  - 7.4.1.2. Retail Sales
    - 7.4.1.2.1. Retail Pharmacies
    - 7.4.1.2.2. Drug Stores
    - 7.4.1.2.3. Online Pharmacies
- 7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Sublingual Allergy Immunotherapy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 7.5.1.2. Brazil Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 7.5.1.3. Brazil Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.4. Brazil Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 7.5.1.5. Mexico Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 7.5.1.6. Mexico Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 7.5.1.7. Mexico Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.8. Mexico Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 7.5.1.9. Argentina Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 7.5.1.10. Argentina Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 7.5.1.11. Argentina Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.12. Argentina Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Sublingual Allergy Immunotherapy Market Outlook, 2018 - 2031

8.1. Middle East & Africa Sublingual Allergy Immunotherapy Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Odactra
  - 8.1.1.2. Grastek
  - 8.1.1.3. Ragwitek
  - 8.1.1.4. Oralair
  - 8.1.1.5. Actair
  - 8.1.1.6. Others
8.2. Middle East & Africa Sublingual Allergy Immunotherapy Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Allergic Rhinitis
  - 8.2.1.2. Allergic Asthma
  - 8.2.1.3. Food Allergy
  - 8.2.1.4. Atopic Dermatitis
  - 8.2.1.5. Others
8.3. Middle East & Africa Sublingual Allergy Immunotherapy Market Outlook, by Allergen Type, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Pollen
    - 8.3.1.1.1. Grass Pollen
    - 8.3.1.1.2. Weed Pollen
    - 8.3.1.1.3. Tree Pollen
  - 8.3.1.2. House Dust Mites
  - 8.3.1.3. Mold
  - 8.3.1.4. Animal Dander
  - 8.3.1.5. Bee Venom
  - 8.3.1.6. Cockroaches/Insects
  - 8.3.1.7. Others
8.4. Middle East & Africa Sublingual Allergy Immunotherapy Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Institutional Sales
    - 8.4.1.1.1. Government Hospitals
    - 8.4.1.1.2. Semi-Government Hospitals
    - 8.4.1.1.3. Private Hospitals
  - 8.4.1.2. Retail Sales
    - 8.4.1.2.1. Retail Pharmacies
    - 8.4.1.2.2. Drug Stores
    - 8.4.1.2.3. Online Pharmacies
- 8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Sublingual Allergy Immunotherapy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 8.5.1.2. GCC Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 8.5.1.3. GCC Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.4. GCC Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.5.1.5. South Africa Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 8.5.1.6. South Africa Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 8.5.1.7. South Africa Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.8. South Africa Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.5.1.9. Egypt Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 8.5.1.10. Egypt Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 8.5.1.11. Egypt Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.12. Egypt Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.5.1.13. Nigeria Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 8.5.1.14. Nigeria Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 8.5.1.15. Nigeria Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.16. Nigeria Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Sublingual Allergy Immunotherapy Market by Drug, Value (US$ Bn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Sublingual Allergy Immunotherapy Market by Indication, Value (US$ Bn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Sublingual Allergy Immunotherapy Market by Allergen Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Sublingual Allergy Immunotherapy Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Product vs Application Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. ALK Abello
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Stallergenes Greer
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Allergy Therapeutics
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Aimmune Therapeutics
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Merck
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Biomay AG
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. HAL Allergy Group
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. DBV Technologies
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Merck KgaA
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. WOLWpharma
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations